Log in
OTCMKTS:AFFY

Affymax Stock Forecast, Price & News

$0.23
+0.01 (+4.52 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.22
Now: $0.23
$0.24
50-Day Range
$0.04
MA: $0.09
$0.22
52-Week Range
$0.01
Now: $0.23
$0.24
Volume217,403 shs
Average Volume75,160 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta3.45
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Read More
Affymax logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:AFFY
CUSIP00826A10
Phone650-812-8700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2
Next Earnings DateN/A
OptionableNot Optionable
$0.23
+0.01 (+4.52 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFFY News and Ratings via Email

Sign-up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Affymax (OTCMKTS:AFFY) Frequently Asked Questions

How has Affymax's stock been impacted by COVID-19?

Affymax's stock was trading at $0.0386 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AFFY stock has increased by 498.4% and is now trading at $0.2310.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Affymax?

Affymax saw a decline in short interest in September. As of September 15th, there was short interest totaling 63,200 shares, a decline of 40.7% from the August 31st total of 106,500 shares. Based on an average daily volume of 144,100 shares, the short-interest ratio is presently 0.4 days.
View Affymax's Short Interest
.

Who are some of Affymax's key competitors?

What other stocks do shareholders of Affymax own?

Who are Affymax's key executives?

Affymax's management team includes the following people:
  • Mr. Mark G. Thompson, CFO & Sec. (Age 57)
  • Mr. Jonathan M. Couchman, CEO, Pres & Director (Age 49)
  • Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 56)

What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

How do I buy shares of Affymax?

Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Affymax's stock price today?

One share of AFFY stock can currently be purchased for approximately $0.23.

What is Affymax's official website?

The official website for Affymax is www.affymax.com.

How can I contact Affymax?

Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.